You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The firm presented data at the European Society for Medical Oncology Virtual Congress last weekend showing how its method could identify signs of early-stage cancers.
Epic may also develop a liquid biopsy test combining the chromosomal instability biomarker with other markers to predict prostate cancer treatment response.
The "EV Click Chip" process involves collecting and purifying extracellular vesicles from a blood sample before performing RT-ddPCR to identify up to 10 early-stage HCC biomarkers.
The method, called jagged end analysis by sequencing and developed by a team in Hong Kong, relies on DNA end repair with methylated or unmethylated cytosine.
The San Diego-based firm anticipates launching an LDT for early-stage lung cancer out of a CLIA-certified, CAP-accredited lab within the next two years.
Mission Bio will use a recent $70 million funding round to develop quality control assays using its Tapestri single-cell analysis platform.
IncellDx is also developing a suite of COVID-19 diagnostic products to answer long-term questions about the treatment of patients still suffering from the disease.
Belgium's OncoDNA believes that IntegraGen's bioinformatics platform will help it manage more cancer patient data and quickly generate patient-specific treatment reports for clinicians.
The group's CureCloud initiative combines patient health data with sequencing data from its liquid biopsy test to help oncologists select treatments.
The firm has partnered with Hackensack Meridian Health to build two reference labs that will provide DNA and RNA profiling for cancer patients.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.